Načítá se...
Clinical applications of mouse models for breast cancer engaging HER2/neu
Human c-ErbB2 (HER2) has long been used as a marker of breast cancer (BC) for sub-categorization for the prediction of prognosis, and determination of therapeutic strategies. HER2 overexpressing BCs are more invasive/metastatic; but patients respond to monoclonal antibody therapy with trastuzumab or...
Uloženo v:
| Vydáno v: | Integr Cancer Sci Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5267336/ https://ncbi.nlm.nih.gov/pubmed/28133539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15761/ICST.1000210 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|